Amgen Inc. (ETR:AMG)
295.60
+0.20 (0.07%)
At close: Nov 28, 2025
Amgen Revenue
Amgen had revenue of $9.56B USD in the quarter ending September 30, 2025, with 12.40% growth. This brings the company's revenue in the last twelve months to $35.97B, up 10.56% year-over-year. In the year 2024, Amgen had annual revenue of $33.42B with 18.57% growth.
Revenue (ttm)
$35.97B
Revenue Growth
+10.56%
P/S Ratio
5.23
Revenue / Employee
$1.28M
Employees
28,000
Market Cap
160.43B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 33.42B | 5.23B | 18.57% |
| Dec 31, 2023 | 28.19B | 1.87B | 7.09% |
| Dec 31, 2022 | 26.32B | 344.00M | 1.32% |
| Dec 31, 2021 | 25.98B | 555.00M | 2.18% |
| Dec 31, 2020 | 25.42B | 2.06B | 8.83% |
| Dec 31, 2019 | 23.36B | -385.00M | -1.62% |
| Dec 31, 2018 | 23.75B | 898.00M | 3.93% |
| Dec 31, 2017 | 22.85B | -142.00M | -0.62% |
| Dec 31, 2016 | 22.99B | 1.33B | 6.14% |
| Dec 31, 2015 | 21.66B | 1.60B | 7.97% |
| Dec 31, 2014 | 20.06B | 1.39B | 7.43% |
| Dec 31, 2013 | 18.68B | 1.41B | 8.17% |
| Dec 31, 2012 | 17.27B | 1.68B | 10.80% |
| Dec 31, 2011 | 15.58B | 529.00M | 3.51% |
| Dec 31, 2010 | 15.05B | 411.00M | 2.81% |
| Dec 31, 2009 | 14.64B | -361.00M | -2.41% |
| Dec 31, 2008 | 15.00B | 232.00M | 1.57% |
| Dec 31, 2007 | 14.77B | 503.00M | 3.53% |
| Dec 31, 2006 | 14.27B | 1.84B | 14.79% |
| Dec 31, 2005 | 12.43B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.87B |
| Siemens Healthineers AG | 23.38B |
| Fresenius SE & Co. KGaA | 22.45B |
| Merck KGaA | 21.27B |
| Fresenius Medical Care AG | 19.64B |
| Sartorius Aktiengesellschaft | 3.52B |
| Redcare Pharmacy NV | 2.82B |
| Fielmann Group AG | 2.42B |
Amgen News
- 2 days ago - Dogs Of The Dow Continue Outperforming Broader Market - Seeking Alpha
- 6 days ago - AMGEN TO PRESENT AT CITI'S 2025 GLOBAL HEALTHCARE CONFERENCE - PRNewsWire
- 6 days ago - AMGEN TO PRESENT AT THE 8TH ANNUAL EVERCORE ISI HEALTHCONX CONFERENCE - PRNewsWire
- 9 days ago - Amgen Shines As Medical Sector Benefits From Sector Rotation - Investor's Business Daily
- 10 days ago - Notable Thursday Option Activity: TGT, CVX, AMGN - Nasdaq
- 10 days ago - $100,000 In The S&P 500's 5 Cheapest Healthcare Stocks, 4% Average Dividend Yield - Seeking Alpha
- 10 days ago - Dow Movers: AMGN, WMT - Nasdaq
- 10 days ago - FDA Grants Full Approval To Amgen's Lung Cancer Drug IMDELLTRA - Nasdaq